Literature DB >> 11176977

External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration: one-year results of a prospective, double-masked, randomized clinical trial.

D M Marcus1, W Sheils, M H Johnson, S B McIntosh, D B Leibach, A Maguire, J Alexander, C N Samy.   

Abstract

OBJECTIVES: To determine the effects of low-dose external beam irradiation compared with observation on the visual function of eyes with subfoveal choroidal neovascularization (CNV) complicating age-related macular degeneration (ARMD).
DESIGN: Prospective, double-masked, randomized clinical trial. Patients randomized to the radiation group received external beam irradiation at a dose of 14 Gy in 7 fractions of 2 Gy. Patients randomized to the observation group received sham radiation.
SETTING: Tertiary care retinal referral practice. PATIENTS: Individuals with classic, mixed, or occult subfoveal CNV secondary to ARMD. MAIN OUTCOME MEASURES: Change in visual acuity from baseline to specified time periods. Secondary outcome variables were contrast sensitivity and fundus photographic/fluorescein angiographic progression.
RESULTS: Forty-two eyes were randomized to observation; 41 eyes, to radiation. Baseline characteristics and demographics did not differ between groups. The median distance visual acuity (DVA) in radiation-treated eyes decreased from 20/80 at baseline to 20/320 (mean loss rate, 4.14 lines) at 1-year follow-up. The median DVA in observation group eyes decreased from 20/125 at baseline to 20/250 (mean loss rate, 3.39 lines) at 1-year follow-up. There were no statistically significant differences in changes in DVA, contrast sensitivity, or fluorescein angiographic progression from baseline between groups at any follow-up period.
CONCLUSIONS: At 1-year follow-up, low-dose external beam irradiation at 14 Gy in 7 fractions of 2 Gy is neither beneficial nor harmful for subfoveal CNV complicating ARMD.

Entities:  

Mesh:

Year:  2001        PMID: 11176977

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  12 in total

1.  Clinicopathological correlation of choroidal neovascularization after external beam radiotherapy in age-related macular degeneration.

Authors:  S Aisenbrey; B A Lafaut; S Reynders; P Szurman; S Grisanti; C Vanden Broecke; P Walter; K U Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-03-22       Impact factor: 3.117

Review 2.  Age related macular degeneration.

Authors:  Amresh Chopdar; Usha Chakravarthy; Dinesh Verma
Journal:  BMJ       Date:  2003-03-01

3.  Radiotherapy for recurrent choroidal neovascularisation complicating age related macular degeneration.

Authors:  D M Marcus; W C Sheils; J O Young; S B McIntosh; M H Johnson; J Alexander; C N Samy
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

4.  Assessment of targeting accuracy of a low-energy stereotactic radiosurgery treatment for age-related macular degeneration.

Authors:  Phillip J Taddei; Erik Chell; Steven Hansen; Michael Gertner; Wayne D Newhauser
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

5.  Ten-year follow-up of eyes treated with stereotactic fractionated external beam radiation for neovascular age-related macular degeneration.

Authors:  Rupan Trikha; Lawrence S Morse; Robert J Zawadzki; John S Werner; Susanna S Park
Journal:  Retina       Date:  2011 Jul-Aug       Impact factor: 4.256

Review 6.  Context for Protons as Adjunctive Therapy in Neovascular Age-Related Macular Degeneration: A Review.

Authors:  Stephanie R Rice; Matthew S J Katz; Minesh P Mehta
Journal:  Int J Part Ther       Date:  2016-03-24

Review 7.  Radiotherapy for neovascular age-related macular degeneration.

Authors:  Jennifer R Evans; Vasuki Sivagnanavel; Victor Chong
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

Review 8.  Current and future treatment options for nonexudative and exudative age-related macular degeneration.

Authors:  Grant M Comer; Thomas A Ciulla; Mark H Criswell; Michael Tolentino
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study.

Authors:  P T Finger; Y P Gelman; A M Berson; A Szechter
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

10.  [Adjuvant stereotactic low energy radiation therapy of exudative age-dependent macular degeneration (Oraya system)].

Authors:  S Pollithy; N Celik; H Höh; S Dithmar
Journal:  Ophthalmologe       Date:  2013-05       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.